These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6028773)

  • 21. The molecular perspective: methotrexate.
    Goodsell DS
    Stem Cells; 1999; 17(5):314-5. PubMed ID: 10527466
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
    Volpato JP; Pelletier JN
    Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
    Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
    Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of peak and trough concentrations to antimicrobial drug therapy.
    Koritz GD
    J Am Vet Med Assoc; 1984 Nov; 185(10):1072-5. PubMed ID: 6392232
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate.
    Galivan J
    Mol Pharmacol; 1980 Jan; 17(1):105-10. PubMed ID: 6155601
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension.
    Gewirtz DA; Plotkin JH; Randolph JK
    Cancer Res; 1984 Sep; 44(9):3846-50. PubMed ID: 6744302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the transport and distribution of diaminopyrimidines in L5178Y lymphoblasts in cell culture.
    Hill BT; Price LA; Harrison SI; Goldie JH
    Biochem Pharmacol; 1975 Feb; 24(4):535-8. PubMed ID: 1078627
    [No Abstract]   [Full Text] [Related]  

  • 31. Structural biology. Dynamic visions of enzymatic reactions.
    Vendruscolo M; Dobson CM
    Science; 2006 Sep; 313(5793):1586-7. PubMed ID: 16973868
    [No Abstract]   [Full Text] [Related]  

  • 32. A bacterial small-molecule three-hybrid system.
    Althoff EA; Cornish VW
    Angew Chem Int Ed Engl; 2002 Jul; 41(13):2327-30. PubMed ID: 12203581
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S; Kadereit B; Schuster D; Balazs Z; Schweizer RA; Frey FJ; Langer T; Odermatt A
    J Mol Endocrinol; 2005 Aug; 35(1):89-101. PubMed ID: 16087724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Directed evolution of trimethoprim resistance in Escherichia coli.
    Watson M; Liu JW; Ollis D
    FEBS J; 2007 May; 274(10):2661-71. PubMed ID: 17451440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Robson C; Meek MA; Grunwaldt JD; Lambert PA; Queener SF; Schmidt D; Griffin RJ
    J Med Chem; 1997 Sep; 40(19):3040-8. PubMed ID: 9301666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect on the animal organism of bacterial enzyme agents designed for the use in the food industry].
    Vissarionova VIa; Skirko BK; Nasyrova LG; Narodetskaia RV; Portnova NG
    Vopr Pitan; 1969; 28(5):41-6. PubMed ID: 5370917
    [No Abstract]   [Full Text] [Related]  

  • 38. Transient induction of phenotypic resistance in human lymphoblastoid cells following sequential use of two antifolates.
    Hamrell MR; Laszlo J; Sedwick WD
    Mol Pharmacol; 1981 May; 19(3):491-5. PubMed ID: 7266473
    [No Abstract]   [Full Text] [Related]  

  • 39. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Papoulis AT; Queener SF
    J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid, radiochemical-ligand binding assay for methotrexate.
    Kamen BA; Takach PL; Vatev R; Caston JD
    Anal Biochem; 1976 Jan; 70(1):54-63. PubMed ID: 1259156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.